Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in PALI — Palisade Bio, Inc.

CIK 1214717 BOSTON, MA
Back to PALI Full portfolio

Position in PALI

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$7,859,413
+$5,153,493 QoQ
Shares Held
3,760,485
+143.2% QoQ
Ownership
2.16%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 124 holders
Holding Since
Mar 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PALI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. PALI ranks #208 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in PALI

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,859,413 3,760,485
2026-03-31 $2,705,920 1,546,240
2025-12-31 $3,678,811 1,565,452
2025-09-30 $22,892 26,620
2025-06-30 $16,817 24,732
2025-03-31 $16,817 24,732
2024-12-31 $16,585 10,052
2024-03-31 $13,779 34,448
2023-12-31 $20,324 34,448
2023-09-30 $19,979 34,448
2023-06-30 $71,819 42,247
2022-09-30 $13,001 130,017
2022-06-30 $53,306 130,017
2022-03-31 $134,552 126,936
2021-12-31 $271,131 208,563
2021-09-30 $454,554 171,530
2021-06-30 $100,427 24,675